Pulmonary atresia: Difference between revisions
| (16 intermediate revisions by 3 users not shown) | |||
| Line 15: | Line 15: | ||
}} | }} | ||
{{Pulmonary atresia}} | {{Pulmonary atresia}} | ||
{{CMG}}; {{AE}} : {{mwaq}} | |||
{{ | {{SK}} | ||
==[[ | ==[[Xyz overview|Overview]]== | ||
==[[ | ==[[Xyz historical perspective|Historical Perspective]]== | ||
==[[Xyz classification|Classification]]== | |||
==[[Xyz pathophysiology|Pathophysiology]]== | |||
==[[Xyz causes|Causes]]== | |||
==[[Xyz differential diagnosis|Differentiating Xyz from other Diseases]]== | |||
==[[Xyz epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Xyz risk factors|Risk Factors]]== | |||
==[[Xyz screening|Screening]]== | |||
==Diagnosis== | |||
[[Xyz diagnostic study of choice|Diagnostic study of choice]] | [[Xyz history and symptoms|History and Symptoms]] | [[Xyz physical examination|Physical Examination]] | [[Xyz laboratory findings|Laboratory Findings]] | [[Xyz electrocardiogram|Electrocardiogram]] | [[Xyz x ray|X-Ray Findings]] | [[Xyz echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Xyz CT scan|CT-Scan Findings]] | [[Xyz MRI|MRI Findings]] | [[Xyz other imaging findings|Other Imaging Findings]] | [[Xyz other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Xyz medical therapy|Medical Therapy]] | [[Xyz interventions|Interventions]] | [[Xyz surgery|Surgery]] | [[Xyz primary prevention|Primary Prevention]] | [[Xyz secondary prevention|Secondary Prevention]] | [[Xyz cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Xyz future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Xyz case study one|Case #1]] | |||
[[Category: (name of the system)]] | |||
==[[Pulmonary atresia epidemiology and demographics|Epidemiology and demographics]]== | ==[[Pulmonary atresia epidemiology and demographics|Epidemiology and demographics]]== | ||
| Line 29: | Line 55: | ||
2) The overall incidence of PA-IVSD is under estimated as most of the fetus are spontaneously aborted due to the underlying other congenital malformations or are diagnosed on routine antenatal ultrasound and results in elective termination. | 2) The overall incidence of PA-IVSD is under estimated as most of the fetus are spontaneously aborted due to the underlying other congenital malformations or are diagnosed on routine antenatal ultrasound and results in elective termination. | ||
- The reported incidence is 6-8 per 100,000 live births and 1-3% of all congenital heart disease. [https://www.uptodate.com/contents/pulmonary-atresia-with-intact-ventricular-septum-pa-ivs?search=pulmonary%20atresia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H172915282][https://emedicine.medscape.com/article/898167-overview#a6] | - The reported incidence is 6-8 per 100,000 live births and 1-3% of all congenital heart disease. [https://www.uptodate.com/contents/pulmonary-atresia-with-intact-ventricular-septum-pa-ivs?search=pulmonary%20atresia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H172915282][https://emedicine.medscape.com/article/898167-overview#a6] | ||
==[[Pulmonary atresia classifications|Classification]]== | ==[[Pulmonary atresia classifications|Classification]]== | ||
| Line 36: | Line 62: | ||
==[[Pulmonary atresia causes|Causes]]== | ==[[Pulmonary atresia causes|Causes]]== | ||
==Diagnosis== | ==Diagnosis== | ||
| Line 50: | Line 67: | ||
==Treatment== | ==Treatment== | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 21:08, 14 July 2020
For patient information click here
| Pulmonary atresia | ||
| ICD-10 | Q25.5 | |
|---|---|---|
| ICD-9 | 747.3 | |
| MedlinePlus | 001091 | |
| MeSH | C14.240.670 | |
|
Pulmonary atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Pulmonary atresia On the Web |
|
American Roentgen Ray Society Images of Pulmonary atresia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Muhammad Waqas, M.D.[2]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Epidemiology and demographics
- While there is no difference in the incidence of Pulmonary atresia in male or female, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males than in females. [1]
1) The prevalence of Pulmonary Atresia with VSD is estimated to be around 0.07 per 1000 live breath. and 2.5-3.4 % among all congenital heart diseases.[3]
2) The overall incidence of PA-IVSD is under estimated as most of the fetus are spontaneously aborted due to the underlying other congenital malformations or are diagnosed on routine antenatal ultrasound and results in elective termination.
- The reported incidence is 6-8 per 100,000 live births and 1-3% of all congenital heart disease. [4][5]
Classification
Natural history, Complications, and Prognosis
Causes
Diagnosis
History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies